All lobbying filings

THE MIZEUR GROUP, LLC

THE MIZEUR GROUP, LLC filed a Q1 report for CLENE NANOMEDICINE on May 20, 2025, reporting $5,000 in lobbying income.

Lobbying for CLENE NANOMEDICINE · Biopharmaceutical company treating neurodegenerative diseases.

All filings by THE MIZEUR GROUP, LLC · Everything CLENE NANOMEDICINE has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted May 20, 2025

Income

$5,000

What the client paid this registrant for the period.

Client based in

Maryland

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Ongoing discussions about regulatory flexibility for accelerated approval of rare disease drugs for neurodegenerative conditions.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.